Stelara (ustekinumab) Subcutaneous Injection, 45 mg/0.5 mL, Single-Dose Vial
Stelara (ustekinumab) is a human interleukin-12/23 monoclonal antibody indicated for the treatment of moderate to severe plaque psoriasis, psoriatic arthritis, and Crohn's disease. This formulation provides 45 mg of ustekinumab in 0.5 mL solution for subcutaneous administration, supplied as a single-dose vial. Each vial is intended for one-time use and should be administered by a healthcare professional.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Stelara (ustekinumab) is a human interleukin-12/23 monoclonal antibody indicated for the treatment of moderate to severe plaque psoriasis, psoriatic arthritis, and Crohn's disease. This formulation provides 45 mg of ustekinumab in 0.5 mL solution for subcutaneous administration, supplied as a single-dose vial. Each vial is intended for one-time use and should be administered by a healthcare professional.
1 vendor
